$HCM #Hutchison China MediTech ADR Hutchison China MediTech - Fortune favours the brave: Notwithstanding the COVID-19 pandemic challenges, Hutchison China MediTech (HCM) remains on track for potential approval and launches of two… https://t.co/km4o3ypww3 #equity #stocks https://t.co/hQVIaxx3B8